First Results on Three Patients Treated with Topical Recombinant Human Erythropoietin (rhEPO) to Improve Wound Healing in Diabetic Foot Ulcers
Journal Title: Journal of Transplantation & Stem Cell Biology - Year 2015, Vol 2, Issue 1
Abstract
Chronic wounds not only induce individual distress but also cause enormous and rapidly growing costs for our health care systems and society in general. The fastest growing groups of chronic wounds are Diabetic Foot Ulcers (DFU), due to the fact that the number of diabetics is growing worldwide. The pathophysiology of DFU is complex and necessitates interventions at multiple levels. Several of these intervention levels can be addressed by topical application of recombinant human Erythropoietin hydro gel (rhEPO hydro gel). We report here the cases of 3 adult patients with controlled diabetes and DFU who were treated in a compassionate healing attempt with topical rhEPO-Hydro gel. In addition patients received state-of-the-art diabetes and DFU treatment. In all three patients complete healing of the DFU with stable long term results could be achieved. Based on these observations, rhEPO hydro gel seems to be a promising treatment option for patients with DFU. GCP conform clinical studies will be necessary to confirm these results in a larger population of patients.
Authors and Affiliations
Christina Irene Guenter
Keywords
Related Articles
- EP ID EP207563
- DOI 10.13188/2374-9326.1000007
- Views 119
- Downloads 0
Generation of Neural Cells by Direct Cellular Reprogramming
Cellular reprogramming is a new technique that is currently explored for its potential to manufacture human cell types in vitro. Direct cellular reprogramming allows the direct conversion of cells into a target cell type...
Organ Bioengineering, Regeneration and Repair: Where the Future of Organ Transplantation is Taking Shape
Although organ transplantation is now widely viewed as one of the monumental achievements in the history of modern medicine, that was not always the case. Indeed, back at the beginning of the 20th century the idea of rep...
Therapeutic Effect of Genistein-Stimulated Human Mesenchymal Stem Cells in Myocardial Infarction
Stem cells offer significant therapeutic promise for the treatment of ischemic diseases. However, stem cells transplanted into ischemic tissue exhibit limited therapeutic efficacy because of poor engraftment in vivo. Sev...
The current knowledge of immune privilege in stem cells
Immune privilege as an active defensive mechanism guards cells and tissues against foreign antigens. Developing tumors and adult stem cells are believed to be immune privileged, since they have the ability to avoid rejec...
Regulation of Hypoxia-Induced Cell Death and Application of Hypoxic Preconditioning to Stem Cell Transplantation
Hypoxia is a commonly encountered feature of the cellular microenvironment in a number of processes in which programmed cell death (apoptosis) affects disease progression. These diseases include myocardial infarction, st...